Baker McKenzie has advised Invitro on the October 17, 2018 sale of its Ukrainian laboratory operations to Medicover.
The operations, which consist of about 60 blood-drawing points and one laboratory, are based primarily in eastern and central Ukraine. The transaction is expected to close in early 2019 and is subject to customary regulatory approvals.
Invitro, which was founded in 1995, is a private medical company in Russia, which specializes in high-precision medical diagnostics and the provision of medical services. The company has a network of medical offices in Eastern Europe, operating nine modern laboratories in six countries.
Medicover, which was also established 1995, is an international healthcare and diagnostic services provider. The company, which was founded in Poland, has since expanded to other countries, and now has operations in Germany, Romania, and Ukraine as well. Medicover provides healthcare services via a network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories through two divisions – Healthcare Services and Diagnostic Services.
Baker McKenzie's team was led by Kyiv-based Partner Olha Demianiuk and included Moscow-based Counsel Dmitry Yeremin.
Baker McKenzie did not reply to our inquires about the deal.
